GC
TARO

GW Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

GW Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$12.3M Sell
79,478
-742
-0.9% -$108K 0.85% 52
2015
Q3 		$11.5M Sell
80,220
-7,466
-9% -$1.04M 0.75% 61
2015
Q2 		$12.6M Sell
87,686
-35,638
-29% -$5.08M 0.67% 63
2015
Q1 		$17.4M Buy
123,324
+32,931
+36% +$5.07M 0.8% 57
2014
Q4 		$13.4M Buy
+90,393
New +$13.3M 0.62% 70

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

GW Capital's TARO Position: Q4 2015 in Review

GW Capital reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 0.92% in Q4 2015, selling an estimated $108K and leaving 79,478 shares worth $12.3M. The position accounts for 0.85% of the portfolio, ranked #52.

GW Capital first reported a position in TARO in Q4 2014 and has held it in 5 quarters since. The position peaked at $17.4M in Q1 2015. 153 funds tracked by Wall St. Rank hold TARO as of Q4 2015.

  • GW Capital held 79,478 shares of Taro Pharmaceutical Industries Ltd. worth $12.3M as of Q4 2015.
  • GW Capital sold 742 Taro Pharmaceutical Industries Ltd. shares in Q4 2015, an estimated $108K.
  • Taro Pharmaceutical Industries Ltd. made up 0.85% of GW Capital's portfolio in Q4 2015, its #52 holding.
  • GW Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and has held it in 5 quarters since.
  • GW Capital's Taro Pharmaceutical Industries Ltd. position peaked at $17.4M in Q1 2015.
  • 153 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2015.

Based on GW Capital's 13F filing for Q4 2015, filed 19 Feb 2016.